Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Lung Cancer
76%
Lobectomy
62%
Neoplasm
55%
Pneumonectomy
44%
Overall Survival
43%
Recurrence Free Survival
31%
Recurrent Disease
28%
Lung
28%
Prognostic Factor
24%
Lymph Node
19%
Video-Assisted Thoracoscopic Surgery
18%
Lymph Node Metastasis
18%
Hazard Ratio
17%
Lung Function
17%
Epithelioma
16%
Esophageal Squamous Cell Carcinoma
15%
Lung Adenocarcinoma
15%
Esophagectomy
15%
Clinical Stage
14%
Retroperitoneal Lymph Node Dissection
14%
Forced Expiratory Volume
13%
Computer Assisted Tomography
13%
Survival Rate
12%
Thoracotomy
12%
Emphysema
11%
Chronic Obstructive Pulmonary Disease
10%
Prevalence
10%
Xenograft
10%
Phase II Trials
10%
Airflow
10%
Epidermal Growth Factor Receptor
10%
Relative Survival
10%
Cisplatin
10%
Docetaxel
10%
Induction Chemotherapy
10%
Disease Free Survival
9%
Squamous Cell Carcinoma
9%
Dyspnea
8%
Proportional Hazards Model
8%
Odds Ratio
8%
Lung Nodule
8%
Adenocarcinoma
7%
Micropapillary
7%
Nodal Metastasis
7%
Metastatic Carcinoma
7%
Non-Small Cell Lung Cancer
7%
Medical Record
6%
Tumor Cell
6%
Surgical Anastomosis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
30%
Neoplasm
21%
Lung Cancer
20%
Overall Survival
20%
Lung Adenocarcinoma
15%
Lymph Node Metastasis
13%
Recurrence Free Survival
11%
Squamous Cell Lung Carcinoma
10%
Phase II Trials
10%
Epithelium Tumor
10%
Docetaxel
10%
Cisplatin
10%
Tumor Classification
10%
Epidermal Growth Factor Receptor
10%
Liver Fibrosis
10%
Recurrent Disease
9%
Prospective Study
5%
Disease Free Survival
5%
Esophageal Squamous Cell Carcinoma
5%
Solid Lipid Nanoparticle
5%
Adenosine A2a Receptor
5%
Metabolic Dysfunction-Associated Steatohepatitis
5%
Mouse Model
5%
